A randomized, controlled, blinded, parallel group, clinical trial to study the role of Ayurcov (AyurCoro3), one day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India

INTRODUCTION: Limited treatment options exist for COVID-19 infections; thus, attempts from complementary and alternative systems (CAM) of medicine are being explored as possible therapeutic options. Ayurcov is a formulation made of ingredients mentioned in Ayurveda. These constituents have proven an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankhe, Ajay Prabhakar, Memane, Nanasaheb Somnath, Gawali, Vijaykumar P., Memane, Sonal Nanasaheb, Ramakrishnan, Ganesh, Kundu, Tapanendu, Bagul, Mayur Nimba, Kumar, Ashotosh, Bansal, Vikram, Tiwari, Rashmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949691/
https://www.ncbi.nlm.nih.gov/pubmed/35341943
http://dx.doi.org/10.1016/j.ctim.2022.102824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949691/
https://www.ncbi.nlm.nih.gov/pubmed/35341943
http://dx.doi.org/10.1016/j.ctim.2022.102824

Ejemplares similares